Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Vir Biotechnology Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 10 Jun 2021 | Vir Biotechnology Inc Enters Phase III Clinical Trial Agreement with Pharmaceutical Product Development LLC for sotrovimab (GDCT0414961) | Contract Service Agreement |
Vir Biotechnology Inc
|
Pharmaceutical Product Development LLC
|
| 06 May 2021 | Vir Biotechnology Inc Enters Phase II Clinical Trial Agreement with Novotech Australia Pty Ltd for VIR-2218, VIR-3434 (GDCT0394869) | Contract Service Agreement |
Vir Biotechnology Inc
|
Novotech Australia Pty Ltd
|
| 17 Feb 2021 | GlaxoSmithKline to Enter into Collaboration Agreement with Vir Biotech for COVID-19 | Partnership | - |
Vir Biotechnology Inc GSK plc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer